Deborah M. Brown
Independent DirectorMs. Deborah M. Brown, B.Sc., M.B.A., ICD.D has been an Independent Director of Oncolytics Biotech Inc. since November 2, 2017. She served as an Independent Director of Sernova Corp. since April 26, 2019 until May 30, 2023. She is currently Lead, Strategic Parternships at EVERSANA Life Science Services, LLC (EVERSANA) since July 2021. She served as Managing Partner at Accelera Canada since May 2017 until July 2021. Ms. Brown has been a Management Consultant since 2014. She had been an Independent Director of Cardiol Therapeutics Inc. since September 2018 until September 2021. She has extensive North American leadership experience. She served as President of EMD Serono, a division of Merck KGaA, Executive Vice President at Serono US, General Manager, Director of Marketing, and Business Unit Director at Serono Canada and Manager, International Regulatory at Pasteur Merieux Connaught. She served as Chair of the National Pharmaceutical Organization (now Innovative Medicines Canada) since 2012 and served on its Director from 2007 to 2014. In 2009, Ms. Brown was inducted into the Canadian Healthcare Marketing Hall of Fame. She serves as Director at Hamilton-Burlington SPCA. She serves on the Boards of Life Sciences Ontario, the Strategic Executive Advisory Council for Canadian Cancer Trials Group and her local SPCA. She is a Management Consultant, Deborah Brown Healthcare Consulting since May 2014. She serves as Director of HBSPCA. Ms. Brown is a former Board Chair and Director of Rx&D and former Board Director of BIOTECanada. Ms. Brown holds an MBA from University of Western Ontario's Ivey School of Business, a B.Sc. (Hons). from the University of Guelph and completed the Merck Executive MBA Program at the University of Hong Kong, INSEAD, and Northwestern University's Kellogg School of Management and the Harvard University Advanced Negotiation Skills program. She completed the Institute of Corporate Directors Designation (ICD.D) in 2019.
Positions
- Company NameOncolytics Biotech Inc.Stock CodeONCYPositionIndependent DirectorColleagues
- JKJared KellyCEO & Director
- WFWayne F. PisanoChairman of the Board
- KJKirk J. LookChief Financial Officer
- TCThomas C. HeinemanChief Medical Officer
- JMJohn McAdoryChief Operating Officer
- AHAllison HagermanChief Technology Officer
- AFAngela Frances HolthamIndependent Director
- JMJonathan M. N. RigbyIndependent Director
